R. Fischer

Commercial Tattooing as a Potentially Important Source of Hepatitis C Infection

Robert W. Haley, R. Fischer · Medicine · 2001 · 153 citations

Medicine, Infectious Diseases, Microbiology +17

Regorafenib in combination with FOLFOX or FOLFIRI as first- or second-line treatment of colorectal cancer: results of a multicenter, phase Ib study

Beate Schultheis, Gunnar Folprecht, Jan Kuhlmann et al. · Annals of Oncology · 2013 · 93 citations · Full text

Medicine, Oncology, Pharmacology +17

The Tattooing Paradox

Robert W. Haley, R. Fischer · Archives of Internal Medicine · 2003 · 43 citations

Medicine, Infectious Diseases, Epidemiologic Methods +12

Effect of nucleotides on the cytosolic free calcium activity and inositol phosphate formation in human glomerular epithelial cells

Hermann Pavenstädt, M. Späth, Günther Schlunck et al. · British Journal of Pharmacology · 1992 · 34 citations · Full text

Life Sciences, Biochemistry, Physiology +16

Impaired cytokine production in whole blood cell cultures from patients with colorectal carcinomas as compared to benign colorectal tumors and controls

Ursula Elsässer‐Beile, S. von Kleist, R. Fischer et al. · Journal of Clinical Laboratory Analysis · 1992 · 26 citations

Medicine, Immunology, Oncology +16